Lantheus soft-launches MR agent at RSNA 2009
An MR contrast agent for blood pool imaging once known as Vasovist reappeared at RSNA 2009 under the new moniker Ablavar.
An MR contrast agent for blood pool imaging once known as Vasovist reappeared at RSNA 2009 under the new moniker Ablavar. Marketing rights to the agent, which the FDA approved a year ago, were sold by Epix Pharmaceuticals for the U.S., Canadian, and Australian markets to Lantheus Medical in April 2009. Lantheus is now working out with the FDA the final labeling details regarding the agent.
The company is aiming for a hard launch of the blood pool agent early next year, pending final labeling from the FDA. The coming U.S. marketing campaign will promote MR procedures enhanced with the newly branded Ablavar as a less invasive option than x-ray angiography for imaging patients with known or suspected peripheral vascular disease, the specific application approved by the FDA for marketing. Lantheus will leverage sales channels used for its other products, including the technetium-based radiotracer Cardiolite and ultrasound contrast agent Definity.
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Large Medicare Study Shows Black Men Less Likely to Receive PET and MRI for Prostate Cancer Imaging
August 4th 2025An analysis of over 749,000 Medicare beneficiaries diagnosed with prostate cancer over a five-year period found that Black men were 13 percent less likely to receive PET imaging and 16 percent less likely to receive MRI in comparison to White men.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 3
August 4th 2025In the last of a three-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, share additional insights on practical considerations and potential challenges in integrating abbreviated breast MRI into clinical practice, and offer their thoughts on future research directions.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 3
August 4th 2025In the third of a three-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, discuss strategies for maintaining the integrity of time-out procedures and communication with remote MRI scanning.
Study Reveals Significant Prevalence of Abnormal PET/MRI and Dual-Energy CT Findings with Long Covid
August 4th 2025In a prospective study involving nearly 100 patients with Long Covid, 57 percent of patients had PET/MRI abnormalities and 90 percent of the cohort had abnormalities on dual-energy CT scans.
